Shensi Shen

18PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersMolecular targetsMicro-manipulationCancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 24, 2026
Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis.

Haoning Peng, Zhile Wang, Mengyao Wang

|Nov 17, 2025
Drug-tolerant persister cells in cancer: bridging the gaps between bench and bedside.

Zhile Wang, Mengyao Wang, Bo Dong

|Mar 03, 2025
Illuminating a Dark Kinase in the Mesenchymal Cancer Cell State.

Shensi Shen, Zhen Tan

|Sep 02, 2024
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.

Mariangela Russo, Mengnuo Chen, Elisa Mariella

|Jul 16, 2024
Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysis.

Bo Dong, Mengyao Wang, Kaixiu Li

|Mar 09, 2024
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.

Jian Zhang, Kejia Zhao, Wenjing Zhou

Pageof 3

Frequent Collaborators

5 joint publications

Caroline Robert

4 joint publications

Stéphan Vagner

3 joint publications

Michaël Cerezo

3 joint publications

Jean-Yves Scoazec